Prospective and randomized comparison of early versus delayed prophylactic administration of granulocyte colony-stimulating factor (filgrastim) in children with cancer

Prospective randomized comparison of mor

Prospective randomized comparison of morning versus night daily single subcutaneous administration of granulocyte-macrophage–colony stimulating factor in patients with soft tissue or bone sarcoma

✍ Dilek Dinçol; Mustafa Samur; Ali Pamir; Orhan Şencan; Hakan Akbulut; Bülent Yalç 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 1 views

## BACKGROUND. Hematopoietic growth factors (HGFs) have been used to reduce the neutropenic complications of cytotoxic chemotherapy so that higher doses may be given. The authors have previously shown that endogenous serum granulocytecolony stimulating factor (G-CSF) and granulocyte-macrophage-colo

Prospective and randomized comparison of early versus delayed prophylactic administration of granulocyte colony-stimulating factor (filgrastim) in children with cancer

✦ Synopsis